Jail-Based hep c cure program shows promise in pilot study

NCT ID NCT06953479

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a low-barrier hepatitis C treatment program can help people in jail start and finish their medication more easily. Forty adults awaiting trial at the Rhode Island Department of Corrections will receive a 12-week course of the antiviral drug Epclusa. If released early, they take the remaining pills with them and get support from community health workers. The goal is to cure their hepatitis C and see if this approach could be used in other jails.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C (HCV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rhode Island Department of Corrections

    RECRUITING

    Cranston, Rhode Island, 02920, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact